59 related articles for article (PubMed ID: 9858905)
21. Anti-invasive effect of contortrostatin, a snake venom disintegrin, and TNF-alpha on malignant glioma cells.
Schmitmeier S; Markland FS; Chen TC
Anticancer Res; 2000; 20(6B):4227-33. PubMed ID: 11205252
[TBL] [Abstract][Full Text] [Related]
22. BCL-xL: time-dependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells.
Weiler M; Bähr O; Hohlweg U; Naumann U; Rieger J; Huang H; Tabatabai G; Krell HW; Ohgaki H; Weller M; Wick W
Cell Death Differ; 2006 Jul; 13(7):1156-69. PubMed ID: 16254573
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
Tysnes BB; Haugland HK; Bjerkvig R
Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion.
Suzuki T; Izumoto S; Fujimoto Y; Maruno M; Ito Y; Yoshimine T
J Clin Pathol; 2005 Feb; 58(2):166-71. PubMed ID: 15677537
[TBL] [Abstract][Full Text] [Related]
25. Interferon entry through the blood-brain barrier in glioma and its effect on lipoxygenase activity.
Wiranowska M; Prockop LD; Naidu AK; Saporta S; Kori S; Kulkarni AP
Anticancer Res; 1994; 14(3A):1121-6. PubMed ID: 7521151
[TBL] [Abstract][Full Text] [Related]
26. Myoepithelial-specific CD44 shedding contributes to the anti-invasive and antiangiogenic phenotype of myoepithelial cells.
Alpaugh ML; Lee MC; Nguyen M; Deato M; Dishakjian L; Barsky SH
Exp Cell Res; 2000 Nov; 261(1):150-8. PubMed ID: 11082285
[TBL] [Abstract][Full Text] [Related]
27. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969
[TBL] [Abstract][Full Text] [Related]
28. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
29. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.
Werbowetski-Ogilvie TE; Agar NY; Waldkircher de Oliveira RM; Faury D; Antel JP; Jabado N; Del Maestro RF
Cancer Res; 2006 Feb; 66(3):1464-72. PubMed ID: 16452202
[TBL] [Abstract][Full Text] [Related]
30. Expression of extracellular matrix components in a highly infiltrative in vivo glioma model.
Mahesparan R; Read TA; Lund-Johansen M; Skaftnesmo KO; Bjerkvig R; Engebraaten O
Acta Neuropathol; 2003 Jan; 105(1):49-57. PubMed ID: 12471461
[TBL] [Abstract][Full Text] [Related]
31. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
32. Lack of In vitro cytotoxicity, associated to increased G(2)-M cell fraction and inhibition of matrigel invasion, may predict In vivo-selective antimetastasis activity of ruthenium complexes.
Zorzet S; Bergamo A; Cocchietto M; Sorc A; Gava B; Alessio E; Iengo E; Sava G
J Pharmacol Exp Ther; 2000 Dec; 295(3):927-33. PubMed ID: 11082425
[TBL] [Abstract][Full Text] [Related]
33. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN
Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
[TBL] [Abstract][Full Text] [Related]
34. Suppression of CD44 expression decreases migration and invasion of human glioma cells.
Okada H; Yoshida J; Sokabe M; Wakabayashi T; Hagiwara M
Int J Cancer; 1996 Apr; 66(2):255-60. PubMed ID: 8603821
[TBL] [Abstract][Full Text] [Related]
35. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines.
Garrison JI; Berens ME; Shapiro JR; Treasurywala S; Floyd-Smith G
J Neurooncol; 1996 Dec; 30(3):213-23. PubMed ID: 8943096
[TBL] [Abstract][Full Text] [Related]
36. In vitro assessment for neurotoxicity of antitumor agents before local administration into central nervous system.
Moriuchi S; Shimizu K; Miyao Y; Yamada M; Ohkawa M; Hayakawa T
Anticancer Res; 1996; 16(1):135-40. PubMed ID: 8615598
[TBL] [Abstract][Full Text] [Related]
37. Cell surface gangliosides are involved in the control of human glioma cell invasion in vitro.
Merzak A; Koochekpour S; Pilkington GJ
Neurosci Lett; 1994 Aug; 177(1-2):44-6. PubMed ID: 7824179
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model.
Wiranowska M; Gonzalvo AA; Saporta S; Gonzalez OR; Prockop LD
J Neurooncol; 1992 Nov; 14(3):225-36. PubMed ID: 1281226
[TBL] [Abstract][Full Text] [Related]
39. Characterization of invading glioma cells using molecular analysis of leading-edge tissue.
Kim CS; Jung S; Jung TY; Jang WY; Sun HS; Ryu HH
J Korean Neurosurg Soc; 2011 Sep; 50(3):157-65. PubMed ID: 22102942
[TBL] [Abstract][Full Text] [Related]
40. Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level.
Klank RL; Decker Grunke SA; Bangasser BL; Forster CL; Price MA; Odde TJ; SantaCruz KS; Rosenfeld SS; Canoll P; Turley EA; McCarthy JB; Ohlfest JR; Odde DJ
Cell Rep; 2017 Apr; 19(3):668. PubMed ID: 28423327
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
